1203943
Last Update Posted: 2019-11-19
Recruiting has ended
All Genders accepted | 50 Years + |
28 Estimated Participants | No Expanded Access |
Interventional Study | Does not accept healthy volunteers |
A Study to Characterize the Safety, PK and Biological Activity of CC-930 in Idiopathic Pulmonary Fibrosis (IPF)
The primary purpose of the study is to evaluate the safety and PK profile of CC-930 in idiopathic pulmonary fibrosis patients.
Eligibility
Relevant conditions:
Idiopathic Pulmonary Fibrosis
Pulmonary Fibrosis
Fibrosis
Interstitial Lung Disease
Lung Diseases, Interstitial
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the study if you think are close to fitting criteria.
locations
Data sourced from ClinicalTrials.gov